Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces Pricing of Initial Public Offering
LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) Rapid Micro Biosystems, Inc. (Nasdaq: RPID) ( Rapid Micro ), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the pricing of its initial public offering of 7,920,000 shares of its Class A common stock at a price to the public of $20.00 per share. All of the shares of Class A common stock are being offered by Rapid Micro. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Rapid Micro, are expected to be $158.4 million, excluding any exercise of the underwriters option to purchase additional shares. Rapid Micro s Class A common stock is expected to begin trading on the Nasdaq Global Select Market under the t
Rapid Micro Biosystems Announces Pricing of Initial Public Offering
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Stifel Announces Pricing of $300 Million of Non-Cumulative Perpetual Preferred Stock
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
LeMaitre Announces Pricing of Public Offering of Common Stock
LeMaitre Vascular, Inc.July 14, 2021 GMT
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $54.50 per share. Gross proceeds to LeMaitre from the offering are expected to be approximately $54.5 million before deducting underwriting discounts and commissions and estimated offering expenses payable by LeMaitre. The offering is expected to close on or about July 16, 2021, subject to customary closing conditions. LeMaitre has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 150,000 shares of common stock at the public offering price, less
LeMaitre Announces Pricing of Public Offering of Common Stock
July 13, 2021 23:03 ET | Source: LeMaitre Vascular, Inc. LeMaitre Vascular, Inc. BURLINGTON, Massachusetts, UNITED STATES
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $54.50 per share. Gross proceeds to LeMaitre from the offering are expected to be approximately $54.5 million before deducting underwriting discounts and commissions and estimated offering expenses payable by LeMaitre. The offering is expected to close on or about July 16, 2021, subject to customary closing conditions. LeMaitre has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 150,000 shares of common st